Comment on: Lipid screening and statins alongside disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis: reply
- PMID: 31873739
- PMCID: PMC8204885
- DOI: 10.1093/rheumatology/kez489
Comment on: Lipid screening and statins alongside disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis: reply
Comment on
-
Lipid screening and statins alongside disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis.Rheumatology (Oxford). 2019 Jun 1;58(6):933-934. doi: 10.1093/rheumatology/key302. Rheumatology (Oxford). 2019. PMID: 30272226 Free PMC article. No abstract available.
-
Comment on: Lipid screening and statins alongside disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis.Rheumatology (Oxford). 2020 Feb 1;59(2):453-454. doi: 10.1093/rheumatology/kez613. Rheumatology (Oxford). 2020. PMID: 31873738 No abstract available.
References
-
- Garton M , McInnes IB , Sattar N. Comment on: lipid screening and statins alongside disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis. Rheumatology 2020;59:453–4. - PubMed
-
- Navarro-Millán I , Cornelius-Schecter A , O’Beirne R et al. Views of primary care physicians and rheumatologists regarding screening and management of hyperlipidemia among patients with rheumatoid arthritis [Abstract]. In: 2018 ACR/ARHP Annual Meeting, 2018. Abstract 504. Chicago, IL. https://acrabstracts.org/abstract/views-of- primary-care-physicians-and-... (1 September 2019, date last accessed). - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
